A culture medium for human umbilical cord mesenchymal stem cells containing traditional Chinese medicine ingredients and its preparation method
By using DMEM/F12 culture medium composed of a specific ratio of traditional Chinese medicine ingredients, the problem of unstable quality of human umbilical cord mesenchymal stem cell culture medium in the existing technology has been solved, achieving efficient expansion and directed differentiation of neuron-like cells, and improving cell viability and differentiation effect.
Patent Information
- Application Number
- CN202611505012.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-24
- Publication Date
- 2026-11-17
AI Technical Summary
In existing technologies, the quality of human umbilical cord mesenchymal stem cell culture media varies, making it difficult to obtain a sufficient number of high-quality cells in a short period of time. Furthermore, the cell expansion process is environmentally sensitive, making it difficult to maintain the cell's growth status and multi-directional differentiation potential.
Using DMEM/F12 culture medium containing traditional Chinese medicine components such as rhodioloside, protocatechuic acid, curcumin, magnolol, chlorogenic acid, L-glutamine, hydrocortisone, insulin, and erythropoietin, the proportion of culture medium components was adjusted to promote the proliferation of human umbilical cord mesenchymal stem cells and the differentiation of neuron-like cells.
This method enables efficient expansion of human umbilical cord mesenchymal stem cells, maintains good cell growth, promotes directed differentiation into neuron-like cells, and improves cell viability and differentiation effect.
Smart Images

Figure CN123107919A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of cell technology, specifically to a culture medium for human umbilical cord mesenchymal stem cells containing traditional Chinese medicine ingredients and its preparation method. Background Technology
[0002] Mesenchymal stem cells (MSCs), as adult stem cells with multi-lineage differentiation capacity, can differentiate into various cell types, including osteoblasts, chondrocytes, nerve cells, muscle cells, and adipocytes. They also possess biological characteristics such as regulating immune responses, promoting tissue repair, and anti-inflammation. MSCs are found in various tissues within the body, such as adipose tissue, umbilical cord, placenta, amnion, skeletal muscle, skin, and bone marrow. Furthermore, MSCs can produce growth factors and cytokines that participate in immune regulation and regeneration. Due to their strong differentiation capacity, MSCs are increasingly being used in the field of regenerative medicine.
[0003] Human umbilical cord mesenchymal stem cells (HCCMS) possess strong self-regenerative capacity and multi-lineage differentiation potential, capable of differentiating into cells from the three germ layers: endoderm, mesoderm, and ectoderm. Under the combined induction of hepatocyte growth factor and fibroblast growth factor, HCCMS can express hepatocyte-specific antigens alpha-fetoprotein (AFP) and albumin, confirming their differentiation into hepatocytes. Simultaneously, under specific in vitro conditions, HCCMS can be induced to differentiate into adipocytes and osteoblasts. Furthermore, HCCMS possesses immunomodulatory capabilities; through homing effects, it can repair damaged cells and stimulate host cell regeneration, autocrine, and paracrine functions.
[0004] The number of primary umbilical cord mesenchymal stem cells isolated from human umbilical cord tissue is extremely small, far from sufficient for application in subsequent cell therapy and tissue engineering. Therefore, how to obtain as many high-quality umbilical cord mesenchymal stem cells as possible in a short period of time is a question worth considering.
[0005] Human umbilical cord mesenchymal stem cells (UC-MSCs) are more fragile and sensitive to their environment than other cells. Therefore, selecting the right culture medium is crucial for cell expansion, as different media significantly impact the expansion rate, cell morphology, and cell quality of UC-MSCs. Currently, numerous culture media for culturing UC-MSCs are available on the market, but their quality varies considerably. Summary of the Invention
[0006] The purpose of this invention is to provide a culture medium for human umbilical cord mesenchymal stem cells containing traditional Chinese medicine ingredients. The culture medium for human umbilical cord mesenchymal stem cells provided by this invention comprises rhodioloside, protocatechuic acid, curcumin, magnolol, chlorogenic acid, L-glutamine, hydrocortisone, insulin, and erythropoietin, with the remainder being DMEM / F12 medium. This medium can promote the proliferation of human umbilical cord mesenchymal stem cells and promote their transformation into neuron-like cells.
[0007] This invention is achieved through the following technical solution: A culture medium for human umbilical cord mesenchymal stem cells containing traditional Chinese medicine ingredients is characterized in that the components of the culture medium include rhodioloside 8-12 μg / mL, protocatechuic acid 12-18 μg / mL, curcumin 8-12 μg / mL, magnolol 10-15 μg / mL, chlorogenic acid 8-12 μg / mL, L-glutamine 4-6 mM, hydrocortisone 6-8 nM, insulin 5-10 μg / mL, erythropoietin 6-8 μg / mL, and the balance being DMEM / F12 culture medium.
[0008] In one embodiment of the present invention, the human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine ingredients comprises rhodioloside 10 μg / mL, protocatechuic acid 15 μg / mL, curcumin 10 μg / mL, magnolol 12 μg / mL, chlorogenic acid 10 μg / mL, L-glutamine 5 mM, hydrocortisone 7 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, and the remainder being DMEM / F12 culture medium.
[0009] In one embodiment of the present invention, the components of the human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine ingredients include rhodioloside 8 μg / mL, protocatechuic acid 15 μg / mL, curcumin 12 μg / mL, magnolol 10 μg / mL, chlorogenic acid 12 μg / mL, L-glutamine 4 mM, hydrocortisone 6 nM, insulin 10 μg / mL, erythropoietin 6 μg / mL, and the balance being DMEM / F12 culture medium.
[0010] In one embodiment of the present invention, the human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine ingredients comprises rhodioloside 10 μg / mL, protocatechuic acid 12 μg / mL, curcumin 10 μg / mL, magnolol 12 μg / mL, chlorogenic acid 8 μg / mL, L-glutamine 5 mM, hydrocortisone 8 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, and the remainder being DMEM / F12 culture medium.
[0011] The method for preparing the human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine components according to the present invention is as follows: (1) Rhodioloside, curcumin and magnolol were dissolved in DMSO to prepare a 10 mg / mL stock solution, which was then sterile filtered for later use. (2) Protocatechuic acid and chlorogenic acid were dissolved in sterile PBS to prepare a 10 mg / mL stock solution, which was then sterilely filtered for later use. (3) L-glutamine was prepared into a 100mM stock solution, hydrocortisone into a 1μM stock solution, insulin into a 1mg / mL stock solution, and erythropoietin into a 10μg / mL stock solution. The solutions were then sterile filtered for later use. (4) Under sterile conditions, take 100 mL of DMEM / F12 culture medium, add each mother liquor according to the ratio, stir and mix at low speed, adjust the pH to 7.3 and the osmotic pressure to 300 mOsm / kg, filter through a 0.22 μm filter to sterilize, and the product is obtained.
[0012] The present invention also provides the application of the aforementioned human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine ingredients.
[0013] In one embodiment of the invention, the application includes culturing human umbilical cord mesenchymal stem cells or promoting the differentiation of human umbilical cord mesenchymal stem cells into neuron-like cells.
[0014] In one embodiment of the present invention, the application is to promote the proliferation of human umbilical cord mesenchymal stem cells.
[0015] The present invention also provides a method for culturing human umbilical cord mesenchymal stem cells, characterized in that the human umbilical cord mesenchymal stem cells are cultured using the above-mentioned human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine components.
[0016] Compared with the prior art, the beneficial effects of the present invention are as follows: Experimental results show that the human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine components of this invention effectively promotes the proliferation of human umbilical cord mesenchymal stem cells and effectively improves the survival rate of cryopreserved human umbilical cord mesenchymal stem cells after resuscitation. The human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine components of this invention is effective in inducing human umbilical cord mesenchymal stem cells to differentiate into neuron-like cells in vitro.
[0017] The human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine ingredients of this invention can not only support the efficient in vitro expansion of human umbilical cord mesenchymal stem cells and maintain the good growth status and biological characteristics of stem cells, but also has a clear neural-directed differentiation induction effect, which can promote the transformation of stem cells into neuron-like cells, providing an ideal in vitro culture and induction system for neural regeneration and stem cell therapy.
[0018] Rhodioloside, protocatechuic acid, curcumin, magnolol, chlorogenic acid and other natural product monomers work synergistically to exert neuroprotective, antioxidant, anti-inflammatory and nerve differentiation-promoting effects. Combined with L-glutamine, hydrocortisone, insulin, erythropoietin and other components, it provides a stable and efficient culture environment for stem cell growth and nerve-directed transformation, and is suitable for research and application related to nerve regeneration, nerve injury repair and stem cell therapy. Attached Figure Description
[0019] Figure 1 Relative expression levels of Nestin, note: compared with the blank control group. & P <0.05, && P <0.01; compared with the positive control group, * P <0.05,** P <0.01; compared with Example 1 group, # P <0.05, ## P <0.01.
[0020] Figure 2 Relative expression level of GFAP, note: compared with the blank control group, & P <0.05, && P <0.01; compared with the positive control group, * P <0.05,** P <0.01; compared with Example 1 group, # P <0.05, ## P <0.01.
[0021] Figure 3 Relative expression level of NEFH, note: compared with the blank control group, & P <0.05, && P <0.01; compared with the positive control group, * P <0.05,** P <0.01; compared with Example 1 group, # P <0.05, ## P <0.01.
[0022] Figure 4 Relative expression level of NSE, note: compared with the blank control group, & P <0.05,&& P <0.01; compared with the positive control group, * P <0.05,** P <0.01; compared with Example 1 group, # P <0.05, ## P <0.01. Detailed Implementation
[0023] The following specific examples illustrate the implementation of the present invention. Those skilled in the art can easily understand other advantages and effects of the present invention from the content disclosed in this specification. The present invention can also be implemented or applied through other different specific embodiments, and various details in this specification can also be modified or changed based on different viewpoints and applications without departing from the spirit of the present invention.
[0024] To make the objectives, technical solutions, and advantages of this invention clearer, the invention will be further described in detail below with reference to specific embodiments. However, this invention is not limited to the following embodiments. It should be noted that, unless otherwise specified, all chemical reagents involved in this invention are purchased through commercial channels.
[0025] The preparation methods of the culture media in Examples 1-6 are as follows: (1) Rhodioloside, curcumin and magnolol were dissolved in DMSO to prepare a 10 mg / mL stock solution, which was then sterile filtered for later use. (2) Protocatechuic acid and chlorogenic acid were dissolved in sterile PBS to prepare a 10 mg / mL stock solution, which was then sterilely filtered for later use. (3) L-glutamine was prepared into a 100mM stock solution, hydrocortisone into a 1μM stock solution, insulin into a 1mg / mL stock solution, and erythropoietin into a 10μg / mL stock solution. The solutions were then sterile filtered for later use. (4) Under sterile conditions, take 100 mL of DMEM / F12 culture medium, add each mother liquor according to the ratio, stir and mix at low speed, adjust the pH to 7.3 and the osmotic pressure to 300 mOsm / kg, filter through a 0.22 μm filter to sterilize, and the product is obtained.
[0026] The preparation methods of the culture media for Comparative Examples 1-9 were adjusted accordingly based on the preparation method of Example 1.
[0027] Example 1 A culture medium for human umbilical cord mesenchymal stem cells containing traditional Chinese medicine ingredients is composed of the following components in the following proportions: rhodioloside 10 μg / mL, protocatechuic acid 15 μg / mL, curcumin 10 μg / mL, magnolol 12 μg / mL, chlorogenic acid 10 μg / mL, L-glutamine 5 mM, hydrocortisone 7 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder being DMEM / F12 culture medium.
[0028] Example 2 A culture medium for human umbilical cord mesenchymal stem cells containing traditional Chinese medicine components, composed of the following components in the following proportions: rhodioloside 8 μg / mL, protocatechuic acid 15 μg / mL, curcumin 12 μg / mL, magnolol 10 μg / mL, chlorogenic acid 12 μg / mL, L-glutamine 4 mM, hydrocortisone 6 nM, insulin 10 μg / mL, erythropoietin 6 μg / mL, with the remainder being DMEM / F12 culture medium.
[0029] Example 3 A culture medium for human umbilical cord mesenchymal stem cells containing traditional Chinese medicine ingredients, composed of the following components in the following proportions: rhodioloside 10 μg / mL, protocatechuic acid 12 μg / mL, curcumin 10 μg / mL, magnolol 12 μg / mL, chlorogenic acid 8 μg / mL, L-glutamine 5 mM, hydrocortisone 8 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder being DMEM / F12 culture medium.
[0030] Example 4 A culture medium for human umbilical cord mesenchymal stem cells containing traditional Chinese medicine ingredients, composed of the following components in the following proportions: rhodioloside 8 μg / mL, protocatechuic acid 18 μg / mL, curcumin 8 μg / mL, magnolol 15 μg / mL, chlorogenic acid 10 μg / mL, L-glutamine 6 mM, hydrocortisone 8 nM, insulin 10 μg / mL, erythropoietin 8 μg / mL, with the remainder being DMEM / F12 culture medium.
[0031] Example 5 A culture medium for human umbilical cord mesenchymal stem cells containing traditional Chinese medicine components, comprising the following components in the following proportions: rhodioloside 12 μg / mL, protocatechuic acid 15 μg / mL, curcumin 8 μg / mL, magnolol 15 μg / mL, chlorogenic acid 12 μg / mL, L-glutamine 6 mM, hydrocortisone 7 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder being DMEM / F12 culture medium.
[0032] Example 6 A culture medium for human umbilical cord mesenchymal stem cells containing traditional Chinese medicine components, comprising the following components in the following proportions: rhodioloside 10 μg / mL, protocatechuic acid 18 μg / mL, curcumin 10 μg / mL, magnolol 12 μg / mL, chlorogenic acid 10 μg / mL, L-glutamine 5 mM, hydrocortisone 6 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder being DMEM / F12 culture medium.
[0033] Comparative Example 1 Protocatechuic acid 15 μg / mL, curcumin 20 μg / mL, magnolol 12 μg / mL, chlorogenic acid 10 μg / mL, L-glutamine 5 mM, hydrocortisone 7 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder in DMEM / F12 medium.
[0034] Rhodioloside was replaced with an equal mass of curcumin, and everything else was the same as in Example 1.
[0035] Comparative Example 2 Rhodioloside 25 μg / mL, curcumin 10 μg / mL, magnolol 12 μg / mL, chlorogenic acid 10 μg / mL, L-glutamine 5 mM, hydrocortisone 7 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder in DMEM / F12 medium.
[0036] Protocatechuic acid was replaced with an equal mass of rhodioloside, otherwise it was the same as in Example 1.
[0037] Comparative Example 3 Rhodioloside 10 μg / mL, protocatechuic acid 15 μg / mL, curcumin 10 μg / mL, chlorogenic acid 22 μg / mL, L-glutamine 5 mM, hydrocortisone 7 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder in DMEM / F12 medium.
[0038] Magnolol was replaced with an equal mass of chlorogenic acid, and everything else was the same as in Example 1.
[0039] Comparative Example 4 Rhodioloside 10 μg / mL, protocatechuic acid 25 μg / mL, magnolol 22 μg / mL, L-glutamine 5 mM, hydrocortisone 7 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder in DMEM / F12 medium.
[0040] It does not contain curcumin or chlorogenic acid, but increases the amount of protocatechuic acid and magnolol, otherwise it is the same as in Example 1.
[0041] Comparative Example 5 Epimedium glycoside 10 μg / mL, protocatechuic acid 15 μg / mL, curcumin 10 μg / mL, magnolol 12 μg / mL, chlorogenic acid 10 μg / mL, L-glutamine 5 mM, hydrocortisone 7 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder in DMEM / F12 medium.
[0042] Icariin was used instead of rhodioloside, otherwise the same as in Example 1.
[0043] Comparative Example 6 Rhodioloside 10 μg / mL, protocatechuic acid 15 μg / mL, crocin 10 μg / mL, magnolol 12 μg / mL, chlorogenic acid 10 μg / mL, L-glutamine 5 mM, hydrocortisone 7 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder in DMEM / F12 medium.
[0044] Replace curcumin with crocin, otherwise it is the same as in Example 1.
[0045] Comparative Example 7 Rhodioloside 10 μg / mL, protocatechuic acid 15 μg / mL, curcumin 10 μg / mL, magnolol 12 μg / mL, resveratrol 10 μg / mL, L-glutamine 5 mM, hydrocortisone 7 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder in DMEM / F12 medium.
[0046] Resveratrol was used instead of chlorogenic acid, otherwise the same as in Example 1.
[0047] Comparative Example 8 Rhodioloside 20 μg / mL, protocatechuic acid 21 μg / mL, curcumin 15 μg / mL, L-glutamine 5 mM, hydrocortisone 7 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder in DMEM / F12 medium.
[0048] It does not contain magnolol or chlorogenic acid, but increases the amounts of rhodioloside, protocatechuic acid, and curcumin; otherwise, it is the same as in Example 1.
[0049] Comparative Example 9 Rhodioloside 15 μg / mL, protocatechuic acid 10 μg / mL, curcumin 15 μg / mL, magnolol 6 μg / mL, chlorogenic acid 15 μg / mL, L-glutamine 5 mM, hydrocortisone 7 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder in DMEM / F12 medium.
[0050] The amount of the components was changed, but everything else remained the same as in Example 1.
[0051] This invention relates to the study of isolating and culturing human umbilical cord mesenchymal stem cells using culture medium. Fresh umbilical cords were aseptically collected and stored in PBS containing heparin and antibiotics, then transported back in an ice box at 4°C and processed within 4 hours. After 30 minutes of ultraviolet irradiation in a clean bench, the umbilical cords were removed, soaked in 75% ethanol, and repeatedly rinsed with physiological saline to remove the outer membrane and umbilical arteries and veins. The umbilical cords were then cut into small pieces approximately 1 mm × 1 mm × 1 mm using ophthalmic scissors. Wharton's jelly was then peeled off and evenly seeded into 100 mm culture dishes, with 6 mL of culture medium from Examples 1-3 and Comparative Examples 1-9 added, and the dishes were incubated at 37°C in a 5% CO2 incubator. The number of culture dishes, the number of tissues seeded, and the weight were consistent for primary human umbilical cord mesenchymal stem cells in Examples 1-3 and Comparative Examples 1-9. Cell morphology was observed under an inverted microscope. Half the medium was replaced after 3 days, and a full medium replacement was performed after 5 days, followed by a full medium replacement every 3 days thereafter. When more than 80% confluence of cells was observed, the cells were passaged.
[0052] Observe the number of days, total number of cells, and cell viability of human umbilical cord mesenchymal stem cells cultured in different culture media to reach the P2 generation.
[0053] After 21 days of cryopreservation, the cells were thawed, and the total number of cells and cell viability of P2 generation human umbilical cord mesenchymal stem cells thawed from a single cryopreservation tube were recorded.
[0054] The results are shown in Table 1.
[0055] Table 1. Effects on the number and viability of human umbilical cord mesenchymal stem cells.
[0056] After 11 days of using the culture medium from Example 1, the cells were passaged to passage P2, with a total cell count of 6.2 × 10⁻⁶. 7 The number of cells was 98%, and the cell viability was 98%.
[0057] Experimental results show that the human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine components of this invention effectively promotes the proliferation of human umbilical cord mesenchymal stem cells. Compared with the culture media of Comparative Examples 1-9, the culture media of Examples 1-3 have significant advantages in terms of total cell count and viability.
[0058] Table 2. Effects on total cell count and cell viability after cryopreservation and thawing of human umbilical cord mesenchymal stem cells.
[0059] The results are shown in Table 2. Cells were cultured using the medium from Example 1 and thawed after 21 days of cryopreservation. The total number of cells in a single cryopreserved tube after thawing was 7.3 × 10⁻⁶. 6 The number of cells was 95%, and the cell viability was 95%.
[0060] Experimental results showed that the human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine components of the present invention resulted in high cell viability after cryopreservation and thawing. Comparative Example 1 replaced rhodioloside with an equal mass of curcumin; Comparative Example 2 replaced protocatechuic acid with an equal mass of rhodioloside; Comparative Example 3 replaced magnolol with an equal mass of chlorogenic acid; Comparative Example 4 did not contain curcumin or chlorogenic acid, but increased the amounts of protocatechuic acid and magnolol; Comparative Example 5 replaced rhodioloside with icariin; Comparative Example 6 replaced curcumin with crocin; Comparative Example 7 replaced chlorogenic acid with resveratrol; Comparative Example 8 did not contain magnolol or chlorogenic acid, but increased the amounts of rhodioloside, protocatechuic acid, and curcumin; Comparative Example 9 changed the amounts of the components. The human umbilical cord mesenchymal stem cell culture medium of the present invention was inferior to Examples 1-3 in terms of promoting proliferation, maintaining cell viability, and cell viability after cryopreservation and thawing. Compared with the culture media of Comparative Examples 1-9, the culture media of Examples 1-3 have a significant advantage in cell viability after cryopreservation and thawing.
[0061] Study on the effect of the culture medium of this invention on the differentiation of human umbilical cord mesenchymal stem cells into neuron-like cells Fourth-generation cells isolated from human umbilical cord mesenchymal stem cells were used. After removing the original culture medium, the cells were washed 1-2 times with phosphate-buffered saline (PBS) to remove residual culture medium. After trypsin treatment, the cells were observed using an inverted microscope. When the cells were observed to be isolated and exhibit a spindle-shaped morphology, an equal volume of complete culture medium was added to stop trypsinization. After adding an appropriate amount of complete culture medium, shaking well, and counting, the cells were counted. Suspension cells were seeded into 12-well and 6-well plates, respectively, and incubated at 37°C and 5% CO2 for 1 week. When the cell density reached 80%, induction was initiated.
[0062] To induce the directed differentiation of human umbilical cord mesenchymal stem cells into neuron-like cells, the culture media provided in Examples 1-3 and Comparative Examples 1-9 of this invention were used for culture treatment, and the specific groupings are as follows: Blank control group: treated with DMEM / F12 medium; Positive control group: treated with DMEM / F12 medium + 20 ng / mL NGF + 10 ng / mL bFGF; Example 1 group: treated with the culture medium of Example 1 + 20 ng / mL NGF + 10 ng / mL bFGF for 14 days; Example 2 group: treated with Example 2 culture medium + 20 ng / mL NGF + 10 ng / mL bFGF for 14 days; Example 3 group: treated with Example 3 culture medium + 20 ng / mL NGF + 10 ng / mL bFGF for 14 days; Comparative Example 1: Treated with Comparative Example 1 culture medium + 20 ng / mL NGF + 10 ng / mL bFGF for 14 days; Comparative Example 2: Treated with Comparative Example 2 culture medium + 20 ng / mL NGF + 10 ng / mL bFGF for 14 days; Comparative Example 3: Treated with Comparative Example 3 culture medium + 20 ng / mL NGF + 10 ng / mL bFGF for 14 days; Comparative Example 4: Treated with Comparative Example 4 culture medium + 20 ng / mL NGF + 10 ng / mL bFGF for 14 days; Comparative Example 5: Treated with Comparative Example 5 culture medium + 20 ng / mL NGF + 10 ng / mL bFGF for 14 days; Comparative Example 6: Treated with Comparative Example 6 culture medium + 20 ng / mL NGF + 10 ng / mL bFGF for 14 days; Comparative Example 7: Treated with Comparative Example 7 medium + 20 ng / mL NGF + 10 ng / mL bFGF for 14 days; Comparative Example 8: Treated with Comparative Example 8 medium + 20 ng / mL NGF + 10 ng / mL bFGF for 14 days; Comparative Example 9: The patients were treated with Comparative Example 9 culture medium + 20 ng / mL NGF + 10 ng / mL bFGF for 14 days.
[0063] The cell culture medium for each group was changed every 3 days, and fresh growth factors were added. On days 7, 10, and 14 of induction culture, the morphological changes of each group of cells were observed and recorded using an inverted phase-contrast microscope, with a focus on evaluating cell shrinkage, protrusion formation, and network-like structure construction.
[0064] Simultaneously, qRT-PCR was used to detect the mRNA expression levels of neural differentiation-related markers. Cells at various time points were collected, and total RNA was extracted using TRIzol reagent. After purity and concentration were determined by Nanodrop, cDNA was synthesized by reverse transcription using the Bestar qPCR RT kit according to the manufacturer's instructions. GAPDH was used as an internal control gene, and qRT-PCR amplification was performed using the SYBR Green method. The reaction program was: 95℃ pre-denaturation for 3 min; 95℃ for 10 s, 60℃ for 30 s, for 40 cycles; followed by melting curve analysis to confirm product specificity. The experiment was repeated three times. The relative expression levels of Nestin, NSE, NEFH, and GFAP were calculated.
[0065] The results are as follows Figures 1-4As shown, compared with the blank control group, the positive control group already showed a trend of neural differentiation: the expression of neural stem cell markers (Nestin) and astrocyte markers (GFAP) was downregulated, while the expression of mature neuron markers (NEFH, NSE) was upregulated. Compared with the positive control group, the differentiation effect of the culture medium in Examples 1-3 and Comparative Examples 1-9 was further enhanced: Nestin expression continued to decrease, while NEFH and NSE expression continued to increase, and the effect of Examples 1-3 was significantly better than that of Comparative Examples 1-9.
[0066] Cytokines are among the most effective methods for inducing the differentiation of human umbilical cord mesenchymal stem cells (UC-MSCs). Commonly used cytokines such as brain-derived neurotrophic factor (BDNF), epidermal growth factor (EGF), and basic fibroblast growth factor (bFGF) can alter the local growth microenvironment and activate intracellular chain reactions by binding to receptors on the surface of pluripotent UC-MSCs, thereby promoting the differentiation of UC-MSCs into neuron-like cells. Experimental results show that the culture media in Examples 1-3 are effective in inducing the differentiation of human umbilical cord mesenchymal stem cells into neuron-like cells in vitro.
[0067] Compared with the culture media of Comparative Examples 1-9, the culture media of Examples 1-3 have a significant advantage in inducing human umbilical cord mesenchymal stem cells to differentiate into neuron-like cells.
[0068] Those skilled in the art should understand that the discussion of any of the above embodiments is merely exemplary and is not intended to imply that the scope of the invention is limited to these examples; within the framework of the invention, the technical features of the above embodiments or different embodiments can also be combined, the steps can be implemented in any order, and there are many other variations of the different aspects of the invention as described above, which are not provided in detail for the sake of brevity.
Claims
1. A culture medium for human umbilical cord mesenchymal stem cells containing traditional Chinese medicine ingredients, characterized in that, The components of the human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine ingredients include rhodioloside 8-12 μg / mL, protocatechuic acid 12-18 μg / mL, curcumin 8-12 μg / mL, magnolol 10-15 μg / mL, chlorogenic acid 8-12 μg / mL, L-glutamine 4-6 mM, hydrocortisone 6-8 nM, insulin 5-10 μg / mL, erythropoietin 6-8 μg / mL, and the balance being DMEM / F12 culture medium.
2. The human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine ingredients according to claim 1, characterized in that, The human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine ingredients comprises rhodioloside 10 μg / mL, protocatechuic acid 15 μg / mL, curcumin 10 μg / mL, magnolol 12 μg / mL, chlorogenic acid 10 μg / mL, L-glutamine 5 mM, hydrocortisone 7 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder being DMEM / F12 culture medium.
3. The human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine ingredients according to claim 1, characterized in that, The human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine ingredients comprises rhodioloside 8 μg / mL, protocatechuic acid 15 μg / mL, curcumin 12 μg / mL, magnolol 10 μg / mL, chlorogenic acid 12 μg / mL, L-glutamine 4 mM, hydrocortisone 6 nM, insulin 10 μg / mL, erythropoietin 6 μg / mL, with the remainder being DMEM / F12 medium.
4. The human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine ingredients according to claim 1, characterized in that, The human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine ingredients comprises rhodioloside 10 μg / mL, protocatechuic acid 12 μg / mL, curcumin 10 μg / mL, magnolol 12 μg / mL, chlorogenic acid 8 μg / mL, L-glutamine 5 mM, hydrocortisone 8 nM, insulin 5 μg / mL, erythropoietin 7 μg / mL, with the remainder being DMEM / F12 culture medium.
5. The method for preparing the human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine components as described in claim 1 is as follows: (1) Rhodioloside, curcumin and magnolol were dissolved in DMSO to prepare a 10 mg / mL stock solution, which was then sterile filtered for later use. (2) Protocatechuic acid and chlorogenic acid were dissolved in sterile PBS to prepare a 10 mg / mL stock solution, which was then sterilely filtered for later use. (3) L-glutamine was prepared into a 100mM stock solution, hydrocortisone into a 1μM stock solution, insulin into a 1mg / mL stock solution, and erythropoietin into a 10μg / mL stock solution. The solutions were then sterile filtered for later use. (4) Under sterile conditions, take 100 mL of DMEM / F12 culture medium, add each mother liquor according to the ratio, stir and mix at low speed, adjust the pH to 7.3 and the osmotic pressure to 300 mOsm / kg, filter through a 0.22 μm filter to sterilize, and the product is obtained.
6. The application of the human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine ingredients as described in any one of claims 1-4.
7. The application according to claim 6, characterized in that, The application is to promote the proliferation of human umbilical cord mesenchymal stem cells.
8. The application according to claim 6, characterized in that, The application is to promote the transformation of human umbilical cord mesenchymal stem cells into neuron-like cells.
9. A method for culturing human umbilical cord mesenchymal stem cells, characterized in that, Human umbilical cord mesenchymal stem cells were cultured using the human umbilical cord mesenchymal stem cell culture medium containing traditional Chinese medicine components as described in any one of claims 1-4.
